BACKGROUND: African Americans have a greater insulin response after glucose challenge than do European Americans. Factors underlying this response are unknown. OBJECTIVE: We determined the insulin, C-peptide, and incretin responses to a mixed macronutrient meal in African American and European American children. We hypothesized that 1) African Americans would have greater postprandial insulin and C-peptide responses, 2) African Americans would have higher incretin responses, and 3) the greater beta cell response among African Americans would be explained by greater incretin responses. DESIGN: Subjects were 34 African American and 18 European American children. Glucose, insulin, C-peptide, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) were measured after the subjects consumed a liquid mixed meal. Insulin, C-peptide, and incretin responses were derived from the area under the curve (AUC) for minutes 0-30 (early response) and minutes 30-180 (late response) after meal ingestion. RESULTS: The early insulin response was higher in African American (14,565 +/- 6840 pmol/L x 30 min) than in European American (7450 +/- 4077 pmol/L x 30 min; P < 0.01) children. Early C-peptide AUC did not differ by ethnicity (African Americans: 34.8 +/- 12.5; European Americans: 28.6 +/- 12.5 nmol/L x 30 min; P = 0.10). Early and late GLP-1 responses were lower in African Americans than in European Americans: 108.1 +/- 56.4 compared with 160.5 +/- 90.8 pmol/L x 30 min and 509.4 +/- 286.9 compared with 781.9 +/- 483.4 pmol/L x 150 min, respectively (P < 0.05 for both). The GIP response did not differ between groups. CONCLUSIONS: The greater early insulin response in African Americans than in European Americans is not due to differences in circulating GLP-1 or GIP and may be due to lesser insulin clearance. Further research is needed to determine the physiologic implications of lower GLP-1 among African Americans.
BACKGROUND: African Americans have a greater insulin response after glucose challenge than do European Americans. Factors underlying this response are unknown. OBJECTIVE: We determined the insulin, C-peptide, and incretin responses to a mixed macronutrient meal in African American and European American children. We hypothesized that 1) African Americans would have greater postprandial insulin and C-peptide responses, 2) African Americans would have higher incretin responses, and 3) the greater beta cell response among African Americans would be explained by greater incretin responses. DESIGN: Subjects were 34 African American and 18 European American children. Glucose, insulin, C-peptide, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) were measured after the subjects consumed a liquid mixed meal. Insulin, C-peptide, and incretin responses were derived from the area under the curve (AUC) for minutes 0-30 (early response) and minutes 30-180 (late response) after meal ingestion. RESULTS: The early insulin response was higher in African American (14,565 +/- 6840 pmol/L x 30 min) than in European American (7450 +/- 4077 pmol/L x 30 min; P < 0.01) children. Early C-peptide AUC did not differ by ethnicity (African Americans: 34.8 +/- 12.5; European Americans: 28.6 +/- 12.5 nmol/L x 30 min; P = 0.10). Early and late GLP-1 responses were lower in African Americans than in European Americans: 108.1 +/- 56.4 compared with 160.5 +/- 90.8 pmol/L x 30 min and 509.4 +/- 286.9 compared with 781.9 +/- 483.4 pmol/L x 150 min, respectively (P < 0.05 for both). The GIP response did not differ between groups. CONCLUSIONS: The greater early insulin response in African Americans than in European Americans is not due to differences in circulating GLP-1 or GIP and may be due to lesser insulin clearance. Further research is needed to determine the physiologic implications of lower GLP-1 among African Americans.
Authors: Barbara A Gower; Wesley M Granger; Frank Franklin; Richard M Shewchuk; Michael I Goran Journal: J Clin Endocrinol Metab Date: 2002-05 Impact factor: 5.958
Authors: Pedro A Velásquez-Mieyer; Patricia A Cowan; Sylvia Pérez-Faustinelli; Ramfis Nieto-Martínez; Cesar Villegas-Barreto; Elizabeth A Tolley; Robert H Lustig; Bruce S Alpert Journal: Diabetes Care Date: 2008-01-09 Impact factor: 19.112
Authors: Kirsten Vollmer; Jens J Holst; Birgit Baller; Mark Ellrichmann; Michael A Nauck; Wolfgang E Schmidt; Juris J Meier Journal: Diabetes Date: 2007-12-05 Impact factor: 9.461
Authors: D Farley; M E Tejero; A G Comuzzie; P B Higgins; L Cox; S L Werner; S L Jenkins; C Li; J Choi; E J Dick; G B Hubbard; P Frost; D J Dudley; B Ballesteros; G Wu; P W Nathanielsz; N E Schlabritz-Loutsevitch Journal: Placenta Date: 2009-07-25 Impact factor: 3.481
Authors: Stephanie T Chung; Mirella Galvan-De La Cruz; Paola C Aldana; Lilian S Mabundo; Christopher W DuBose; Anthony U Onuzuruike; Mary Walter; Ahmed M Gharib; Amber B Courville; Arthur S Sherman; Anne E Sumner Journal: J Clin Endocrinol Metab Date: 2019-01-01 Impact factor: 5.958
Authors: Sarah Bartz; Aaloke Mody; Christoph Hornik; James Bain; Michael Muehlbauer; Tonny Kiyimba; Elizabeth Kiboneka; Robert Stevens; John Bartlett; John V St Peter; Christopher B Newgard; Michael Freemark Journal: J Clin Endocrinol Metab Date: 2014-02-27 Impact factor: 5.958
Authors: P C Chandler-Laney; P B Higgins; W Granger; J Alvarez; K Casazza; J R Fernandez; C Dalla Man; C Cobelli; B A Gower Journal: Pediatr Obes Date: 2013-02-28 Impact factor: 4.000
Authors: Sara F Michaliszyn; SoJung Lee; Fida Bacha; Hala Tfayli; Lama Farchoukh; Andrea Mari; Ele Ferrannini; Silva Arslanian Journal: Pediatr Diabetes Date: 2016-01-22 Impact factor: 4.866
Authors: V M H Tan; Y S Lee; K Venkataraman; E Y H Khoo; E S Tai; Y S Chong; P Gluckman; M K S Leow; C M Khoo Journal: Nutr Diabetes Date: 2015-07-20 Impact factor: 5.097
Authors: Tae Jung Oh; Hye Seung Jung; Jae Hyun Bae; Yeong Gi Kim; Kyeong Seon Park; Young Min Cho; Kyong Soo Park; Seong Yeon Kim Journal: J Korean Med Sci Date: 2013-06-03 Impact factor: 2.153